• Mashup Score: 0
    Amyloidosis Forum 2023: ATTR Drug Development - 10 month(s) ago

    Recorded and edited interviews for the “Patient Perspectives: Today’s Unmet Need” session at the 2023 Amyloidosis Forum meeting.

    Source: YouTube
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Amyloidosis_ARC
      Amyloidosis_ARC

      Researchers, life science companies, & other #ATTR #amyloidosis HCPs: What's really important to patients and caregivers? For the #AmyloidosisForum we worked with @MathewMaurer to ask patients how the next phase of #drugdevelopment will impact their lives https://t.co/Jp151XzO7l

  • Mashup Score: 1
    FDA and NIH/NCI Center for Cancer Research - 1 year(s) ago

    FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes. Virtual 2-day free public workshop.

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      May 16-17: @FDAOncology @NCIResearchCtr Public Workshop to Advance #DrugDevelopment in #MDS. 2 days w/experts from govt, academia, pharma, patient advocates discussing optimal #clinicaltrials design. #mdssm @KellyNorsworth2 @StevenPavletic Info/Register: https://t.co/GEUdT0quqC https://t.co/EdGZeAyBsZ

  • Mashup Score: 0
    FDA and NIH/NCI Center for Cancer Research - 1 year(s) ago

    FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes. Virtual 2-day free public workshop.

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      May 16-17: @FDAOncology @NCIResearchCtr Public Workshop to Advance #DrugDevelopment in #MDS. 2 days w/experts from govt, academia, pharma, patient advocates discussing optimal #clinicaltrials design. #mdssm @KellyNorsworth2 @StevenPavletic Info/Register: https://t.co/GEUdT0quqC https://t.co/eveWBf8rr4

  • Mashup Score: 25
    Take the Course - Progress for Patients - 1 year(s) ago

    Through the ProgressForPatients.org Advocacy Education Program, we’ll educate and empower you to make the connections necessary to engage with the drug development process and communicate your experience.

    Source: Progress for Patients
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of tmprowell
      tmprowell

      Are you interested in becoming involved in patient #advocacy? Here’s a free 90 min course: https://t.co/8fs8Gn5x6p. #drugdevelopment #clinicaltrials #MedTwitter @CancerResrch

    • Profile photo of CancerResrch
      CancerResrch

      RT @tmprowell: Are you interested in becoming involved in patient #advocacy? Here’s a free 90 min course: https://t.co/8fs8Gn5x6p. #drugde…

  • Mashup Score: 4
    FDA and NIH/NCI Center for Cancer Research - 1 year(s) ago

    FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes. Virtual 2-day free public workshop.

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      May 16-17: @FDAOncology @NCIResearchCtr Public Workshop to Advance #DrugDevelopment in #MDS. 2 days w/experts from govt, academia, pharma, patient advocates discussing optimal #clinicaltrials design. #mdssm @KellyNorsworth2 @StevenPavletic Info/Register: https://t.co/GEUdT0quqC https://t.co/vMJi3k133t

  • Mashup Score: 1
    FDA and NIH/NCI Center for Cancer Research - 1 year(s) ago

    FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes. Virtual 2-day free public workshop.

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      May 16-17: @FDAOncology @NCIResearchCtr Public Workshop to Advance #DrugDevelopment in #MDS. 2 days w/experts from govt, academia, pharma, patient advocates discussing optimal #clinicaltrials design. #mdssm @KellyNorsworth2 @StevenPavletic Info/Register: https://t.co/GEUdT0quqC https://t.co/FSuxTCGCBX

  • Mashup Score: 1
    FDA and NIH/NCI Center for Cancer Research - 1 year(s) ago

    FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes. Virtual 2-day free public workshop.

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      May 15-16: @FDAOncology @NCIResearchCtr Public Workshop to Advance #DrugDevelopment in #MDS. 2 days w/experts from govt, academia, pharma, patient advocates discussing optimal #clinicaltrials design. #mdssm @KellyNorsworth2 @StevenPavletic Info/Register: https://t.co/GEUdT0quqC https://t.co/IwktnQ28Pc

  • Mashup Score: 0
    Kick off your week with the latest healthcare funding. | LinkedIn - 1 year(s) ago

    Fundings Orbital Therapeutics, a South San Francisco-based startup established just a year ago, has secured $270 million in Series A funding. This comes as interest grows in startups that leverage cutting-edge RNA technologies to develop pharmaceuticals and vaccines. ARCH Venture Partners took the lead in this investment round. Vedanta Biosciences,…

    Source: www.linkedin.com
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of TWDigitalHealth
      TWDigitalHealth

      Start your week with the latest #healthcare fundings - Orbital Therapeutics, Evommune, and more. #digitalhealth #drugdiscovery #drugdevelopment https://t.co/YwnTWq19EZ https://t.co/mlN3ap7ku0

Load More